Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06941935

Etiological Classification-guided Individual Intervention in Primary Hypertension

Etiological Classification-guided Individual Intervention in Primary Hypertension: An All-comer Registry Study

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
2,000 (estimated)
Sponsor
Shanghai 10th People's Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Eligible participants will first undergo a 1-week home blood pressure diary and 24-hour ambulatory blood pressure assessment. After a confirmed diagnosis of hypertension, etiological subtyping will be performed. Based on the blood pressure evaluation results and etiological classification, the most appropriate antihypertensive medication will be selected. Simultaneously, a personalized lifestyle prescription will be provided according to the patient's individual circumstances. Following medication initiation, participants will continue to monitor their blood pressure through home diaries. Monthly evaluations will be conducted, and if blood pressure fails to reach the target value, medication adjustments will be made based on the blood pressure diary until target levels are achieved. This regimen will be maintained long-term.

Conditions

Interventions

TypeNameDescription
OTHEREtiological Classification and Digital InterventionEligible participants will first undergo a 1-week home blood pressure diary and 24-hour ambulatory blood pressure assessment. After a confirmed diagnosis of hypertension, etiological subtyping will be performed. Based on the blood pressure evaluation results and etiological classification, the most appropriate antihypertensive medication will be selected. Simultaneously, a personalized lifestyle prescription will be provided according to the patient's individual circumstances. Following medication initiation, participants will continue to monitor their blood pressure through home diaries. Monthly evaluations will be conducted, and if blood pressure fails to reach the target value, medication adjustments will be made based on the blood pressure diary until target levels are achieved. This regimen will be maintained long-term.

Timeline

Start date
2025-06-01
Primary completion
2030-12-31
Completion
2030-12-31
First posted
2025-04-24
Last updated
2025-04-24

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT06941935. Inclusion in this directory is not an endorsement.